Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Tesla
TSLA
|
+$3.32B |
| 2 |
Microsoft
MSFT
|
+$280M |
| 3 |
Morgan Stanley
MS
|
+$265M |
| 4 |
American Tower
AMT
|
+$262M |
| 5 |
Charles Schwab
SCHW
|
+$261M |
Top Sells
| 1 |
TIF
Tiffany & Co.
TIF
|
+$206M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
+$200M |
| 3 |
ETFC
E*Trade Financial Corporation
ETFC
|
+$186M |
| 4 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$151M |
| 5 |
Pfizer
PFE
|
+$132M |
Sector Composition
| 1 | Technology | 24.26% |
| 2 | Healthcare | 13.6% |
| 3 | Financials | 13.04% |
| 4 | Consumer Discretionary | 12.4% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3126
Genprex
GNPX
$8.37M
| $1.84M | ﹤0.01% |
11,086
+968
| +10% | +$161K |
|
|
BCLI
3127
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $1.84M | ﹤0.01% |
27,062
+402
| +2% | +$27.3K |
|
3128
Avalo Therapeutics
AVTX
$145M
| $1.83M | ﹤0.01% |
241
+20
| +9% | +$152K |
|
3129
BHP
BHP
$135B
| $1.83M | ﹤0.01% |
31,389
-1,420
| -4% | -$82.7K |
|
3130
Quad
QUAD
$327M
| $1.83M | ﹤0.01% |
478,851
+1,538
| +0.3% | +$5.87K |
|
3131
Larimar Therapeutics
LRMR
$342M
| $1.83M | ﹤0.01% |
85,407
+16,914
| +25% | +$362K |
|
|
EXTN
3132
DELISTED
Exterran Corporation
EXTN
| $1.83M | ﹤0.01% |
413,443
+19,571
| +5% | +$86.5K |
|
3133
Duluth Holdings
DLTH
$135M
| $1.82M | ﹤0.01% |
172,292
-2,384
| -1% | -$25.2K |
|
3134
BGSF Inc
BGSF
$71.8M
| $1.82M | ﹤0.01% |
134,831
+5,808
| +5% | +$78.3K |
|
|
ESTE
3135
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $1.82M | ﹤0.01% |
341,093
+24,507
| +8% | +$131K |
|
3136
Chemung Financial Corp
CHMG
$252M
| $1.82M | ﹤0.01% |
53,530
+479
| +0.9% | +$16.3K |
|
|
RDS.B
3137
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $1.81M | ﹤0.01% |
53,983
-1,209
| -2% | -$40.6K |
|
|
IMDX
3138
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$85.9M
| $1.81M | ﹤0.01% |
37,888
+8,472
| +29% | +$405K |
|
|
HOOK
3139
DELISTED
HOOKIPA Pharma
HOOK
| $1.81M | ﹤0.01% |
16,308
+1,671
| +11% | +$185K |
|
3140
Maravai LifeSciences
MRVI
$376M
| $1.81M | ﹤0.01% |
+64,438
| New | +$1.81M |
|
|
ESSA
3141
DELISTED
ESSA Bancorp
ESSA
| $1.79M | ﹤0.01% |
119,256
-142
| -0.1% | -$2.13K |
|
3142
Equinor
EQNR
$62.9B
| $1.79M | ﹤0.01% |
108,767
-14,865
| -12% | -$244K |
|
|
GFN
3143
DELISTED
General Finance Corporation
GFN
| $1.78M | ﹤0.01% |
208,827
+7,859
| +4% | +$66.9K |
|
|
NBSE
3144
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $1.77M | ﹤0.01% |
12,697
+741
| +6% | +$104K |
|
|
XONE
3145
DELISTED
The ExOne Company
XONE
| $1.77M | ﹤0.01% |
186,724
+20,683
| +12% | +$196K |
|
3146
Aurinia Pharmaceuticals
AUPH
$1.61B
| $1.77M | ﹤0.01% |
126,499
+10,576
| +9% | +$148K |
|
3147
PCB Bancorp
PCB
$308M
| $1.76M | ﹤0.01% |
174,536
-289
| -0.2% | -$2.92K |
|
|
WPG
3148
DELISTED
Washington Prime Group Inc.
WPG
| $1.76M | ﹤0.01% |
270,277
+20,169
| +8% | +$131K |
|
3149
iShares Core S&P 500 ETF
IVV
$670B
| – | – |
0
| – | -$1.46M |
|
3150
Eagle Bancorp Montana
EBMT
$138M
| $1.76M | ﹤0.01% |
82,765
+6,223
| +8% | +$132K |
|